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Abstract  
Background: Music therapy during palliative and end-of-life care is well established 
and positive benefits for patients have been reported.   
Aim: Assess the effectiveness of music therapy versus standard care alone or 
standard care in combination with other therapies for improving psychological, 
physiological and social outcomes among adult patients in any palliative care setting.  
Data sources: In order to update an existing Cochrane systematic review, we 
searched MEDLINE, CINAHL, EMBASE, PsycINFO, CENTRAL, ClinicalTrials.gov 
register, and Current Controlled Trials register to identify randomised or quasi-
randomised controlled trails published between 2009 and April 2015. Nine electronic 
music therapy journals were searched from 2009 until April 2015, along with 
reference lists and contact was made with key experts in music therapy. Only studies 
published in English were eligible for inclusion. Two reviewers independently 
screened titles, abstracts, assessed relevant studies for eligibility, extracted data and 
judged risk of bias for included studies. Disagreements were resolved through 
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discussion with a third reviewer. Data were synthesised in Revman using the random 
effects model. Heterogeneity was assessed using l2.  
Results: Three studies were included in the review. Findings suggest music therapy 
may be effective for helping to reduce pain in palliative care patients (standard mean 
deviation (SMD) = -0.42, 95% CI -0.68 to -0.17, P = 0.001).  
Conclusions: Available evidence did not support the use of music therapy to improve 
overall quality-of-life in palliative care. While this review suggests music therapy may 
be effective for reducing pain, this is based on studies with a high risk of bias. 
Further high quality research is required. 
Keywords 
Palliative care, music therapy, quality of life, pain, systematic review 
Introduction 
Music therapy has been defined as the use of music and sounds to facilitate the 
development of a relationship between patients and professionally trained therapists 
with the aim of supporting relaxation and improving both physical and emotional well-
being.1  Music therapy has been  employed in palliative and end-of-life care for more 
than a decade to help address the associated psychological and spiritual issues,2 
which often lie beyond the remit of traditional healthcare.3  
Although music therapy has been widely implemented in palliative and end-of-life 
care settings both in the United Kingdom3 and the United States,5 evidence to 
support its effectiveness with this client group is equivocal6 and there is a need to 
examine the current state of the evidence to ensure that ongoing service 
developments are evidence based.  
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This systematic review will examine recent developments in the field by updating an 
existing Cochrane Systematic review7 originally conducted in 2009. 
Similar to the previous study7 the questions addressed will include: (a) is music 
therapy and standard care more effective than standard care alone or standard care 
combined with other therapies; (b) are different types of music therapy (e.g. 
improvisation, music listening, lyric writing) more effective? 
 
Methods   
Searches were based on the strategy employed in Bradt and Dileo’s previous 
Cochrane review.7 We searched seven databases, trials registers, and key electronic 
journals from 2009 until April 2015 (See Appendix 1). Reference lists of relevant 
studies were also checked to identify further studies. Titles and abstracts of all 
retrieved articles were screened for eligibility using pre-defined criteria (see 
Appendix 2). Full text articles were retrieved when the title or abstract could not be 
rejected with confidence. A record was kept of all excluded studies along with the 
reason for exclusion. Data were extracted using a standardized coding form. Any 
discrepancies in data extraction were discussed and resolved by all three review 
authors. Risk of bias was assessed using the Cochrane Handbook’s risk of bias tool8 
Main outcomes were presented as continuous variables. Standardised mean 
differences (SMDs) were calculated for continuous data using available mean values 
and their standard deviations (SD), together with 95% confidence intervals (CIs).  
We estimated the treatment effects of individual trials and examined heterogeneity 
between trials by inspecting the forest plots and quantifying the impact of 
heterogeneity using the I2 statistic: low (> 25% and < 50%), moderate (≥ 50% and < 
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75%) and high heterogeneity (≥ 75%).9 Where heterogeneity was suspected we 
investigated possible causes, such as differences in study quality and participants. 
To measure the impact of heterogeneity on the meta-analysis, the I2 was used to 
describe the percentage of variability in effect estimates due to heterogeneity rather 
than chance. No heterogeneity was indicated with I2 = 0%. We planned to use funnel 
plots in order to examine potential bias from selective publication, but were unable to 
do so as only two published studies were included. 
Meta-analysis employing a random effects model was performed using Review 
Manager Software version 5.2.10 Subgroup analyses were planned to explore: a) 
different types of music therapy interventions; b) different duration and frequency of 
music therapy. However, because of the small numbers of studies included, these 
analyses were not completed. Again, sensitivity analyses were planned to examine 
the influence of study quality by comparing results with and without low-quality 
studies. However, all included studies were rated as containing a high risk of bias. 
Results 
5 
 
Figure 1 summarises the review process and results. Only one study completed 
since the previous Cochrane review7 was deemed eligible to be added for this review 
update.  
Figure 1. Flow diagram of systematic review update process 
 
Bradt and Dileo’s review7 identified five eligible studies examining the effect of music 
therapy on end-of-life care in a range of outcomes such as: pain, depression, quality 
of life, functional well-being, psychological wellbeing and, social/spiritual well-being.  
The authors concluded that there was insufficient evidence to support the use of 
music therapy in end-of-life care.  Our searches identified one additional paper11 
which examined the effect of music therapy on pain amongst this client population 
and we sought to combine these findings with two relevant papers included in the 
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original review.12,13  Combining these studies provided a total of 245 participants 
randomised to music therapy and 243 participants completing the studies. Two 
studies were conducted in the United States11,13 and one in Australia12.  All patients 
were adults with a mean age of 64.7. Participants had a range of diagnoses 
including cancer, congestive heart failure and renal failure. Characteristics of the 
included studies from both the 2009 and the current review are presented in table 1. 
All studies were rated as having a high risk of bias due to the studies failure to blind 
assessors to outcomes.  
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Table 1. Characteristics of the included studies (N = 3). 
Author, Year, 
Country 
Study design Participants Intervention Outcome Measures Results 
Gutgsell et al. 
(2013), USA  
Randomised 
Controlled Trial 
(RCT) 
 
Power (%) 80 
 
Sample size:198 
198 hospital inpatients with a diagnosis 
of advanced, potentially life-limiting 
illness. Patients were 18 years or older, 
able to understand English, alert enough 
to be able to rate pain on a numeric 
scale, and have pain on a numeric rating 
scale of three or more (on a scale of 
Zero to 10). 
Patients mean age was 56 years. 
Music therapy: (n = 99) a professional 
music therapist delivered individual 
music therapy sessions focused on 
lowering pain levels. A standard protocol 
was used for all patients. Comfort 
measures included placing a ‘Do not 
disturb’ notice on the door, adjusting 
lights, providing a blanket and turning 
off any phones. This was followed by 
verbal instructions for autogenic 
relaxation which included focusing on 
relaxing muscles from the head to the 
feet; imagining a safe place of the 
patient’s own choice, and what they 
imagined seeing, smelling, hearing, 
tasting and feeling on their skin in this 
safe place. The therapist used the ocean 
drum, followed by the harp while the 
patient continued to focus on their safe 
place. The music, played at a low volume 
in a slow tempo, was chosen by the 
therapist based on clinical experience. 
Control:  (n = 99) The same comfort 
measures as for the intervention group. 
Number of sessions: 1 
Length of session: 20 minutes 
1. The Numeric 
Rating Scale 
(NRS) 
2. The Face, 
Legs, 
Activity, Cry, 
Consolability 
Scale 
(FLACC)  
3. The 
Functional 
Pain Scale 
(FPS) 
 
Pain was 
significantly 
lowered for the 
music therapy 
group compared to 
the control group 
for NRS and FPS. No 
significant 
improvement was 
observed for 
FLACC. 
Difference in 
means between 
music therapy and 
control group for 
pain 
 - Numeric Rating 
Scale (NRS) -1.39 
(1.99) (p < 0.0001),  
- The Face, Legs, 
Activity, Cry, 
Consolability Scale 
(FLACC) -0.34 (1.68) 
(p> 0.05) 
- The Functional 
Pain Scale (FPS) -
0.52 (0.95) (p< 
0.0001) 
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Horne-
Thompson et 
al.  
(2008) 
Australia 
RCT 
 
Power (%) 80 
 
Sample size: 25 
25 hospice inpatients receiving palliative 
care for a diagnosis of a terminal illness. 
Patients who were referred to music 
therapy for anxiety, passed a routine 
cognitive functioning test, and able to 
speak English were eligible. 
Patients mean age was 73.9 years. 
Music therapy: (n=13) a registered music 
therapist provided a range of techniques 
which included singing, playing familiar 
live or recorded music, music and 
relaxation, music and imagery, 
improvisation, and music assisted 
counselling. The technique used was 
chosen based on consultation with the 
participant.  
Control: (n=12)a single volunteer session 
consisting of conversation, reading or 
offering emotional support to the 
participant. 
Number of sessions: 1 
Length of session: 20-40 minutes 
1. The 
Edmonton 
Symptom 
Assessment 
System 
(ESAS) 
2. A pulse 
oximeter 
Results showed 
anxiety was 
significantly 
reduced for the 
experimental group 
(p 0.005). A post 
hoc analysis 
showed significant 
reductions in other 
measurements on 
the ESAS in the 
experimental group 
for pain (p 0.019), 
tiredness (p 0.024) 
and drowsiness (p 
0.018).  
No difference in 
heart rate was 
found between 
experimental and 
control group. 
Nguyen 
(2003) 
United States 
RCT 
 
Power (%) No 
power 
calculation  
 
Sample size:20 
20 adult hospice inpatients receiving 
palliative care for end of life. Patients 
were eligible if they had 2 or more: no 
DNR (do not resuscitate) poor or grave 
prognosis, prescribed terminally ill and 
receiving comfort measures only.  
Patients mean age was 64.5 years. 
Music therapy: (n = 10) the first session 
involved singing music chosen by the 
patient, finding out the patient’s 
favourite songs, and assessing the 
patient and family’s coping levels. The 
second session involved an end of life 
celebration. 
Control: (n= 10)standard care only 
Number of sessions: 2 
Length of session: not reported 
1. Hospice 
Quality of 
Life Index-
Revised 
Visual Annalog Scale 
measured: 
1. Anxiety 
2. Pain 
3. Sadness 
4. Stress 
5. Hope  
6. Discomfort  
Anxiety was 
significantly 
reduced for the 
experimental 
group.  
No significant 
difference was 
found for quality of 
life between the 
two groups. 
(no statistical 
results provided for 
pain; posttest 
scores calculated 
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from raw data 
within Appendix). 
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Table 2 shows the results of a meta-analysis examining the impact of music therapy 
for palliative patients on pain. Overall, a statistically significant difference was shown 
in pain reduction favouring the intervention group when compared to those who 
received comfort measures, a volunteer visit, or standard care only (three studies, n= 
243; SMD -0.42, 95% CI -0.68, -0.17, P=0.001) (Table 2). Overall, the test for 
homogeneity passed with an I2 value of 0%.  
Table 2. Efficacy: Music therapy versus active control and standard care only for 
pain 
 
 
Discussion 
The previous systematic review7 established no strong evidence of music therapy’s 
effectiveness for reducing pain based on a meta-analysis of two small studies 
(n=45). However, the addition of Gutsgell et al.’s study11 to this updated review 
suggests that there is a significant effect for music therapy in reducing pain among 
palliative care patients. This is an important finding given that pain is a common 
symptom reported by palliative care patients in a wide range of life-limiting illnesses 
such as cancer, heart disease, chronic obstructive pulmonary disease, renal disease 
and acquired immunodeficiency disease.14 Furthermore, a recent review examining 
the utilisation of music therapy for palliative care indicated that most referrals were 
made to alleviate pain.2 
Study or Subgroup 
Gutsgell 
Horne-Thompson 
Nguyen 
Total (95% CI) 
Heterogeneity: Tau² = 0.00; Chi² = 0.44, df = 2 (P = 0.80); I² = 0% 
Test for overall effect: Z = 3.27 (P = 0.001) 
Mean 
4.74 
1.77 
23 
SD 
2.59 
2.39 
33.31 
Total 
99 
13 
10 
122 
Mean 
5.86 
2.25 
42.9 
SD 
2.42 
2.73 
38.74 
Total 
99 
12 
10 
121 
Weight 
81.4% 
10.5% 
8.1% 
100.0% 
IV, Random, 95% CI 
-0.45 [-0.73, -0.16] 
-0.18 [-0.97, 0.61] 
-0.53 [-1.42, 0.37] 
-0.42 [-0.68, -0.17] 
Music therapy Control Std. Mean Difference Std. Mean Difference 
IV, Random, 95% CI 
-1 -0.5 0 0.5 1 
Favours [experimental] Favours [control] 
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Like the previous systematic review7 we were unable to verify music therapy’s 
effectiveness for improving communication or social outcomes for palliative care 
patients due to the lack of evidence. 
However, RCTs may not be the only appropriate way to assess the benefits of music 
therapy. Other methodologies, which seek to elucidate its processual and qualitative 
aspects, also have an important contribution to make.15 Qualitative research 
suggests that music therapy is beneficial to palliative care patients such as helping 
them express difficult emotions,16 helping patients and families find closure at the 
end of life,9 and improving staff mood and resilience.4,10 
A strength of this review is that we built upon existing work and conducted a 
comprehensive search of several databases and music therapy journals, checked 
reference lists of all considered studies, and used strict eligibility criteria for reviewed 
publications. However, due to resource limitations we were only able to consider 
articles in the English language. 
In addition, due to the nature and quality of studies identified it was not possible to 
carry out subgroup analysis to investigate type of music therapy or duration as 
moderator variables. Further large scale RCTs are required to inform the 
development of music therapy interventions for palliative patients.  
Conclusion 
One advantage of synthesizing the available evidence is that it illustrates clearly the 
limited extent of our knowledge in this area and highlights the ongoing need for good 
quality research to guide policy makers and service planners.  A key finding in this 
study was that, during a five-year period, only one new study had been conducted to 
help inform the development of music therapy services amongst this client group.  
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This review indicates that music therapy may be effective for reducing pain in 
palliative care patients. This adds to the previous review’s finding that it may be 
effective for improving quality of life.7 However, these results are based on findings 
from studies with a high risk of bias. 
The findings of this systematic review, whilst encouraging, demonstrate that, at 
present, the beneficial therapeutic effects of music therapy for the palliative care 
population have not been fully demonstrated. This lack of evidence highlights an 
urgent need for methodologically rigorous trials of clearly defined music therapy 
interventions with common outcome measures. Such a strategy would enable 
healthcare policy makers and commissioners to make fully informed decisions about 
the role that music therapy should play in palliative care.  
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Appendix 1 
 
Database: MEDLINE (www.nlm.nih.gov/bsd/pmresources.html) 
Date: 2009 to April 2015 
Total: 42 
Strategy:  
1  randomized controlled trial.pt. (397786) 
2  controlled clinical trial.pt. (90503) 
3  random allocation.sh. (83769) 
4  double blind method.sh. (131902) 
5  single blind method.sh. (20448) 
6  or/1-5 (567019) 
7  (animals not humans).sh. (3987869) 
8  6 not 7 (516832) 
9  exp Clinical Trial/ (812011) 
10 ((singl* or doubl* or trebl* or tripl*) adj (blind* or mask*)).ti,ab. (129466) 
11 placebo.sh. (33956) 
12 “placebo*”.ti,ab. (159165) 
13 “random*”.ti,ab. (689992) 
14 research design.sh. (81937) 
15 or/9-14 (1293126) 
16 15 not 7 (1190534) 
17 16 not 8 (691845) 
18 comparative study.sh. (1726213) 
19 exp Evaluation Studies/ (205134) 
20  follow up studies.sh. (516468) 
21 prospective studies.sh. (388663) 
22 (control* or prospective* or volunteer*).ti,ab. (2653016) 
23  or/18-22 (4719952) 
24 23 not 7 (3679436) 
25 24 not (8 or 17) (11134) 
26 8 or 17 or 35 (1214099) 
27  palliative care/ or terminal care/ or hospice care/ or terminally ill/ (64964) 
28  “hospice*”.tw. (8287) 
29 (palliat* or (terminal* adj6 ill*) or (terminal* adj3 care) or (end adj3 life)).tw. (61654) 
30 ((care adj5 dying) or (caring adj5 dying) or (support$ adj5 dying) or (dying adj5 
patient$)).tw. (7188) 
31 ((advanced adj6 cancer) or (advanced adj6 carcinoma$) or (advanced adj6 neoplasm$) or 
(terminal$ adj6 cancer$) or (terminal$ adj6 carcinoma$) or (metastatic adj6 cancer) or 
(metastatic$ adj6 cancer$) or (metastat$ adj6 carcinoma$) or (metastas$ adj6 carcinoma$) or 
(metastatic adj6 neoplasm$) or (metastas$ adj6 neoplasm$)).tw. (141185) 
32 exp heart failure, congestive/ (91265) 
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33 exp liver failure/ (19064) 
34 exp kidney failure/ (129759) 
35  amyotrophic lateral sclerosis/ (13790) 
36 exp Acquired Immunodeficiency Syndrome/ (75269) 
37 exp pulmonary disease, chronic obstructive/ ( 38111) 
38 (heart failure or cardiac failure or liver failure or kidney failure or renal failure or AIDS or 
ALS or COPD).tw. (355532) 
39  or/29-38 (722201) 
40 music therapy/ (2456) 
41  (music$ or melod$).tw. (12727) 
42  (sing or sings or singer$ or singing or song$).tw. (9900) 
43  or/40-42 (22087) 
44 39 and 43 (583) 
45  26 and 44 (85) 
46 limit 45 to yr= “2009 – 2014” (42)   
 
Database:  PsycINFO (http://www.apa.org/pubs/databases/psychinfo/index.aspx) 
Date: 2009 to April 2015 
Total: 87 
Strategy:  
1 palliative care/ or terminal care/ or hospice care/ or terminally ill/ (10479) 
2 hospice$.tw. (3700) 
3 (palliate$ or (terminal$ adj6 ill$) or (terminal$ adj3 care) or (end adj3 life)).tw. 
(14773) 
4 ((care adj5 dying) or (caring adj5 dying) or (support$ adj5 dying) or (dying adj5 
patient$)).tw. (2634) 
5 ((advanced adj6 cancer) or (advanced adj6 carcinoma$) or (advanced adj6 neoplasm$) 
or (terminal$ adj6 cancer$) or (terminal$ adj6 carcinoma$) or (metastatic adj6 cancer) 
or (metastas$ adj6 cancer$) or (metastat$ adj6 carcinoma$) or (metastas$ adj6 
carcinoma$) or (metastatic adj6 neoplasm$) or (metastas$ adj6 neoplasm$)).tw. 
(3484) 
6 Congestive heart failure.mp. (673) 
7 kidney failure.mp. (110) 
8 liver failure.mp. (200) 
9 amyotrophic lateral schlerosis.mp. (3140) 
10 exp AIDS/ (13048) 
11 chronic obstructive pulmonary disease.mp. (1521) 
12 (heart failure or cardiac failure or liver failure or kidney failure or renal failure or 
amyotrophic lateral sclerosis or AIDS or ALS or COPD or chronic obstructive 
pulmonary disease).tw. (43926) 
13 Or /1-12 (63321) 
14 music therapy/ (3402) 
15 music/ (11593) 
16 (music$ or melod$).tw. (28925) 
17 (sing or sings or singer$ or singing or song$).tw. (10716) 
18 Or/14-17 (37203) 
19 empirical study.md. (1789879) 
20 followup study.md. (50543) 
21 longitudinal study.md. (110025) 
22 prospective study.md. (26739) 
23 quantitative study.md. (950976) 
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24 “2000”.md. (28109) 
25 treatment effectiveness evaluation/ (17395) 
26 exp hypothesis testing/ (2510) 
27 repeated measures/ (583) 
28 exp experimental design/ (48315) 
29 placebo$.ti,ab. (31456) 
30 random$.ti,ab. (134926) 
31 (clin$ adj25 trial$).ti,ab. (27668) 
32 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab. (20080) 
33 Or/19-32 (1858542) 
34 13 and 18 and 33 (216) 
limit 34 to (human and yr="2009 -Current") (87) 
Database: CINAHL (http://www.ebscohost.com/academic/cinahl-plus-with-full-text) 
Date: 2009 to April 2015 
Total: 138 
Strategy:  
1 (MH “Music Therapy”) (3,046) 
2 (MH “singing”) OR “sing” (1,839) 
3 “singer*” (573) 
4 “song*” (1,050) 
5 “music*” (10.064) 
6 “melod*” (243) 
7 “music therapy” (3,164) 
8 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 (12,008) 
9 advanced N6 cancer* (9,305) 
10 advanced N6 carcinoma* (1,443) 
11 advanced N6 neoplasm* (43) 
12 terminal* N6 cancer* (1,100) 
13 terminal* N6 carcinoma* (27) 
14 metastas* N6 cancer* (3,404) 
15 metastat* N6 carcinoma* (1,688) 
16 metastas* N6 carcinoma* (1,474) 
17 metastas* N6 neoplasm* (18,632) 
18 metastat* N6 neoplasm* (63) 
19 metastat* N6 cancer* (5,686) 
20 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 (34,051) 
21 (MH “Terminally Ill Patients”) OR (MH “Hospice Patients”) (8,122) 
22 (MH “Terminal Care”) OR (MH “Hospice Care”) OR (MH “Palliative Care”) (35,418) 
23 care N5 dying (1,976) 
24 caring N5 dying (500) 
25 support* N5 dying (263) 
26 dying N5 patient* (2,531) 
27 palliat* N6 ill* (527) 
28 terminal* N6 Ill* (9,817) 
29 terminal* N3 care (12,698) 
30 end N3 life (10,499) 
31 “hospice” (12,889) 
32 (MH “Hospice Patients”) (256) 
33 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 (46,712) 
34 8 AND 20 AND 33 (12) 
35 20 OR 33 (77,494) 
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36 8 AND 35 (303) 
37 8 AND 35 (Limited to <2009 to 2014>) (138) 
 
Database: CENTRAL (www.cochrane.org) 
Date: 2009 to April 2015 
Total: 36 
Strategy:  
MeSH descriptor PALLIATIVE CARE this term only 
MeSH descriptor TERMINAL CARE this term only 
MeSH descriptor HOSPICE CARE this term only 
(palliat* in Title, Abstract or Keywords or (terminal* in Title, Abstract or Keywords near/6 ill* 
in Title, Abstract or Keywords) or (terminal* in Title, Abstract or Keywords near/6 care in Title, 
Abstract or Keywords) or (end in Title, Abstract or Keywords near/6 life in Title, Abstract or 
Keywords) ) 
( (care in Title, Abstract or Keywords near/6 dying in Title, Abstract or Keywords) or (caring in 
Title, Abstract or Keywords near/6 dying in Title, Abstract or Keywords) or (support* in Title, 
Abstract or Keywords near/6 dying in Title, Abstract or Keywords) or (patient* in Title, 
Abstract or Keywords near/6 dying in Title, Abstract or Keywords) ) 
( (advanced in Title, Abstract or Keywords near/6 cancer in Title, Abstract or Keywords) or 
(advanced in Title, Abstract or Keywords near/6 carcinoma* in Title, Abstract or Keywords) or 
(advanced in Title, Abstract or Keywords near/6 neoplasm* in Title, Abstract or Keywords) or 
(terminal* in Title, Abstract or Keywords near/6 cancer* in Title, Abstract or Keywords) or 
(terminal* in Title, Abstract or Keywords near/6 carcinoma* in Title, Abstract or Keywords) or 
(metastatic in Title, Abstract or Keywords near/6 cancer* in Title, Abstract or Keywords) or 
(metastas* in Title, Abstract or Keywords near/6 cancer* in Title, Abstract or Keywords) or 
(metastatic in Title, Abstract or Keywords near/6 carcinoma* in Title, Abstract or Keywords) or 
(metastas* in Title, Abstract or Keywords near/6 carcinoma* in Title, Abstract or Keywords) or 
(metastatic in Title, Abstract or Keywords near/6 neoplasm* in Title, Abstract or Keywords) or 
(metastas* in Title, Abstract or Keywords near/6 neoplasm* in Title, Abstract or Keywords) ) 
MeSH descriptor HEART FAILURE explode all trees 
MeSH descriptor LIVER FAILURE explode all trees 
MeSH descriptor RENAL INSUFFICIENCY explode all trees 
MeSH descriptor NEURODEGENERATIVE DISEASES explode all trees 
MeSH descriptor ACQUIRED IMMUNODEFICIENCY SYNDROME this term only 
(heart next failure in Title, Abstract or Keywords or liver next failure in Title, Abstract or 
Keywords or kidney next failure in Title, Abstract or Keywords) 
“AIDS” in Title, Abstract or Keywords 
neurodegenerative in Title, Abstract or Keywords 
(#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15) 
MeSH descriptor MUSIC THERAPY this term only 
music* in Title, Abstract or Keywords 
melod* in Title, Abstract or Keywords 
(sing in Title, Abstract or Keywords or sings in Title, Abstract or Keywords or singer* in Title, 
Abstract or Keywords or singing in Title, Abstract or Keywords or song* in Title, Abstract or 
Keywords) 
(#17 or #18 or #19 or #20) 
(#16 and #21) limited to Publication Year from 2009 to 2014 (36) 
 
Database: EMBASE (http://www.elsevier.com/online-tools/embase) 
Date: 2009 to April 2015 
Total: 172 
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Strategy:  
1 randomized controlled trial/ (353243) 
2 exp controlled clinical trial/ (487963) 
3 exp randomization/ (63967) 
4 double blind procedure/ (116034) 
5 single blind procedure/ (19033) 
6 1 or 2 or 3 or 4 or 5 (564138) 
7 clinical trial/ (834048) 
8 (clin* adj25 trial*).ti,ab. (360497) 
9 singl*.ti,ab. (1290854) 
10 doubl*.ti,ab. (485029) 
11 trebl*.ti,ab. (432) 
12 tripl*.ti,ab. (94904) 
13 blind*.ti,ab. (270928) 
14 mask*.ti,ab. (62531) 
15 9 or 10 or11 or 12 (1760700) 
16 13 or 14 (331358) 
17 15 and 16 (179646) 
18 placebo*.ti,ab. (204147) 
19 random*.ti,ab. (913640) 
20 18 or 19 (991352) 
21 placebo.sh. (247319) 
22 methodology.sh. (1384991) 
23 21 or 22 (1627002) 
24 7 or 8 or 17 or 20 or 23 (3053428) 
25 comparative study.sh. (646554) 
26 follow up.sh. (852227) 
27 prospective study.sh. (266630) 
28 25 or 26 or 27 (1654016) 
29 exp evaluation study/ (10112) 
30 control*.ti,ab. (3167675) 
31 prospectiv*.ti,ab. (615132) 
32 volunteer.ti,ab. (21212) 
33 30 or 31 or 32 (3651252) 
34 8 or 29 or 33 (4807148) 
35 palliative care/ (52118) 
36 terminal care/ (24222) 
37 hospice care/ (6239) 
38 terminally ill/ (5952) 
39 35 or 36 or 37 or 38 (76523) 
40 “hospice*”.tw. (11247) 
41 palliat*.tw. (68820) 
42  (terminal* adj3 ill).tw. (7150) 
43 (terminal* adj3 care).tw. (2779) 
44 (end adj3 life).tw. (17891) 
45 41 or 42 or 43 or 44 (86652) 
46 (care adj5 dying).tw. (2767) 
47 (caring adj5 dying).tw. (568) 
48 (support$ adj5 dying).tw. (371) 
49 (dying adj5 patient$).tw. (6975) 
50 46 or 47 or 48 or 49 (8746) 
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51 (advanced adj6 cancer).tw. (74962) 
52 (advanced adj6 carcinoma$).tw. (22234) 
53 (advanced adj6 neoplasm$).tw. (962) 
54 (terminal* adj6 cancer$).tw. (3681) 
55 (terminal$ adj6 carcinoma$).tw. (428) 
56 (metastatic adj6 cancer).tw. (56002) 
57 (metastas$ adj6 cancer$).tw. (62979) 
58 (metastat$ adj6 carcinoma$).tw. (27923) 
59 (metastas$ adj6 carcinoma$).tw. (31691) 
60 (metastatic adj6 neoplasm$).tw. (1923) 
61 (metastas$ adj6 neoplasm$).tw. (2182) 
62 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 (242279) 
63 exp congestive heart failure/ (76337) 
64 exp liver failure/ (46318) 
65 exp kidney failure/ (226546) 
66 amyotrophic lateral schlerosis/ (22979) 
67 exp acquired immune deficiency syndrome/ (128659) 
68 pulmonary disease, chronic obstructive.mp. or exp chronic obstructive lung disease 
(72504) 
69 39 or 40 or 45 50 or 62 or 63 or 64 or 65 or 66 or 67 or 68 (897665) 
70 music therapy/ (4347) 
71 music$.tw. 15698) 
72 melod$.tw. (1949) 
73 sing.tw. (1170) 
74 sings.tw. (940) 
75 singer$.tw. (2022) 
76 singing.tw. (2235) 
77 song$.tw. (7879) 
78 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 (29348) 
79 69 or 78 (781) 
80 6 or 24 or 34 (6847533) 
81 79 and 80 (325) 
82 limit 81 to yr= “2009-Current” (172) 
 
Database: ClinicalTrials.gov (https://clinicaltrials.gov/) 
Date: 2009 to April 2015 
Total: 765 
Strategy:  
Music OR (music therapy) OR singing OR song OR songs OR melody  
 
Database: Current Controlled Trials (www.webcitation.org) 
Date: April 2015 
Total: 58 
Strategy:  
Music OR music therapy  
Sing OR sings OR singing OR song OR songs OR melody OR melodies 
 
Electronic Databases 
Date: 2009 to April 2015 
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1. Australian Journal of Music Therapy 
2. Canadian Journal of Music Therapy 
3. Journal of Music Therapy 
4. Music Therapy Perspectives 
5. Nordic Journal of Music Therapy 
6. Voices (online international journal of music therapy) 
7. New Zealand Journal of Music Therapy 
8. The Arts in Psychotherapy 
9. Journal of Evidence-Based Complementary and Alternative Medicine 
 
Appendix 2 
Inclusion criteria for systematic review of music therapy for end-of-life care 
Study Type Randomised Controlled Trials (published or unpublished) 
 
 Quasi-randomised or systematic methods of treatment allocation (e.g. 
alternate allocation of treatment 
 
Participants Specialist Palliative care or hospice settings (inpatient or community) 
 
 Any setting with a diagnosis of advanced life-limiting illness being treated 
with palliative intent and with life expectancy of less than two years 
 
Type of intervention Standard care combined with music therapy compared to: 
1. standard care alone 
2. standard care combined with other therapies 
 
Delivered by 1. Formally trained music therapist or by trainees in a formal music 
therapy program 
2. Therapeutic process present 
 
Personally tailored 
music therapy 
interventions used 
in an individual or 
group setting 
1. Listening to live, therapist-composed, patient-composed, therapist 
and patient-composed, improvised, or pre-recorded music 
2. Performing music on an instrument 
3. Improvising music spontaneously using voice or instruments, or 
both. 
 
Outcome measures 
for patient 
1. Symptom relief (e.g. of nausea, fatigue, pain) 
2. Psychological  outcomes (anxiety, depression, fear) 
3. Physiological outcomes (e.g. respiratory rate, heart rate, IgA 
levels) 
4. Relationship ad social support (e.g. family support, isolation) 
5. Communication (e.g. verbilization, facial affect, gestures) 
6. Quality of life 
7. Spirituality 
8. Participant satisfaction  
 
Outcome measures 
for family 
members/caregivers 
1. Psychological outcomes (e.g. depression, distress, coping, grief) 
2. Relationship and social support 
3. Communication with participant 
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4. Quality of life 
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